Literature DB >> 5824077

Studies of bilirubin kinetics in normal adults.

P D Berk, R B Howe, J R Bloomer, N I Berlin.   

Abstract

This report describes studies of bilirubin kinetics in 13 healthy young adults. The plasma content of unconjugated bilirubin-(14)C was determined at frequent intervals for 24-30 hr after the intravenous injection of a tracer dose of unconjugated isotopic bilirubin. Fecal and urinary radioactivity were measured for 7 days. During this time cumulative recovery averaged 96% of the injected dose. The plasma curves were processed by digital computer. For the 30 hr experimental period, a sum of three exponentials, with average half-times of 18, 81, and 578 min, was required to describe the data. Using the plasma curve integral method, the hepatic bilirubin clearance (47 +/-10 ml/min, mean +/-SD), the bilirubin production rate (3.8 +/-0.6 mg/kg per day), and the mean red blood cell life span (101 +/-13 days) were calculated directly from the parameters of this function. To gain further insight into the metabolism of unconjugated bilirubin, the data were also used to determine the parameters of a multicompartmental model. In the model proposed, plasma unconjugated bilirubin exchanges with two additional pools one of which is thought to represent extrahepatic extravascular, and the other intrahepatic unconjugated bilirubin. Bilirubin is eliminated from the system via the proposed intrahepatic pool. From the data and the model, pool sizes and exchange rates between compartments were calculated, and the liver: plasma concentration gradient estimated. These studies provide a detailed analysis of the kinetics of unconjugated bilirubin in a healthy normal population and are intended to serve as a reference point for studies of abnormal states.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5824077      PMCID: PMC297471          DOI: 10.1172/JCI106184

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  FECAL DYE MARKERS IN METABOLIC BALANCE STUDIES. THE USE OF BRILLIANT BLUE AND METHYLCELLULOSE FOR ACCURATE SEPARATION OF STOOL PERIODS.

Authors:  L Lutwak; B T Burton
Journal:  Am J Clin Nutr       Date:  1964-02       Impact factor: 7.045

2.  The potential life span and ultimate survival of fresh red blood cells in normal healthy recipients as studied by simultaneous Cr51 tagging and differential hemolysis.

Authors:  G S EADIE; I W BROWN
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

3.  The formulation and testing of models.

Authors:  M BERMAN
Journal:  Ann N Y Acad Sci       Date:  1963-05-10       Impact factor: 5.691

4.  Short-lived red cells in normal individuals.

Authors:  R L EVANS
Journal:  Nature       Date:  1954-01-16       Impact factor: 49.962

5.  The application of multicompartmental analysis to problems of clinical medicine. Combined clinical staff conference at the National Institutes of Health.

Authors:  N I Berlin; M Berman; P D Berk; J M Phang; T A Waldmann
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

6.  Metabolism and excretion of C14-labeled bilirubin in children with biliary atresia.

Authors:  J L Cameron; R M Filler; F L Iber; T Abei; J G Randolph
Journal:  N Engl J Med       Date:  1966-02-03       Impact factor: 91.245

7.  Hepatic intracellular distribution of tritium-labeled unconjugated and conjugated bilirubin in normal and Gunn rats.

Authors:  L H Bernstein; J B Ezzer; L Gartner; I M Arias
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

8.  [Kinetics of bilirubin metabolism--an approach to a new procedure for diagnosing jaundice].

Authors:  Y Araki; T Miyasaki; M Kashima; S Oomori; H Ogawa
Journal:  Nihon Rinsho       Date:  1966-06

9.  Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital, nonhemolytic, unconjugated hyperbilirubinemia, and kernicterus.

Authors:  J F Crigler; N I Gold
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

10.  THE HEPATIC UPTAKE AND EXCRETION OF SULFOBROMOPHTHALEIN AND BILIRUBIN.

Authors:  C A GORESKY
Journal:  Can Med Assoc J       Date:  1965-04-17       Impact factor: 8.262

View more
  48 in total

1.  Effects of various arterial infusion solutions on red blood cells in the newborn.

Authors:  J K Jackson; D P Derleth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

2.  Population studies on Gilbert's syndrome.

Authors:  D Owens; J Evans
Journal:  J Med Genet       Date:  1975-06       Impact factor: 6.318

Review 3.  Systems dynamics in clinical pharmacokinetics. An introduction.

Authors:  J M van Rossum; J E de Bie
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

4.  Structural identifiability of strongly connected biological compartmental systems.

Authors:  C Cobelli; G Romanin-Jacur
Journal:  Med Biol Eng       Date:  1975-11

Review 5.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

6.  Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.

Authors:  Kevin A Strauss; Charles E Ahlfors; Kyle Soltys; George V Mazareigos; Millie Young; Lauren E Bowser; Michael D Fox; James E Squires; Patrick McKiernan; Karlla W Brigatti; Erik G Puffenberger; Vincent J Carson; Hendrik J Vreman
Journal:  Hepatology       Date:  2020-02-05       Impact factor: 17.425

7.  An expanded model of bilirubin kinetics: effect of feeding, fasting, and phenobarbital in Gilbert's syndrome.

Authors:  G Kirshenbaum; D M Shames; R Schmid
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

8.  The management of neonatal hyperbilirubinemia-Part I.

Authors:  W J Cashore; Leo Stern
Journal:  Indian J Pediatr       Date:  1986-09       Impact factor: 1.967

9.  Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency.

Authors:  W C Mentzer; R L Baehner; H Schmidt-Schönbein; S H Robinson; D G Nathan
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

10.  The use of jejunal transplants to treat a genetic enzyme deficiency.

Authors:  B M Jaffe; A A Burgos; M Martinez-Noack
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.